Our translational research platform unites leading researchers and clinicians across a variety of disciplines to develop improved methods of disease surveillance and treatment.
We want to support research and clinical trials that will help us learn how to engineer the microbiome to help patients and restore health. These efforts are supported by a strong foundation of resources: our Microbial Omics Core Facility, Data Analysis Pipeline, and the The Broad Institute-OpenBiome Microbiome Library.
Crosstalk between the PD-1: PD-L Pathway and the MicrobiomePrimary Researcher:
Advancing Engineered Microbes for IBD Diagnostics and TreatmentsPrimary Researcher: